FCGR2B and lobular neoplasia: Decreased terminal galactosylation of IgG N-glycans (50, 51) leads to a reduced binding affinity between antibodies and FcγRIIB, the activation of C1q, the upregulation of the CDC effect, and the promotion of the occurrence and development of inflammation, all of which may contribute to the pathogenesis of LN (52).